ミドスタウリンの世界市場2020-2026:AML、ASM、SM-AHN又はMCL

QYResearchが発行した調査報告書(QYR20AP02102)
◆英語タイトル:Global Rydapt Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP02102
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:112
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、ミドスタウリンの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、ミドスタウリンのグローバル市場動向、メーカー別競争状況、種類別市場規模(AML、ASM、SM-AHN又はMCL)、用途別市場規模(病院、薬局)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・ミドスタウリンの種類別市場2015-2026:AML、ASM、SM-AHN又はMCL
・ミドスタウリンの用途別市場2015-2026:病院、薬局
・ミドスタウリンの北米市場分析
・ミドスタウリンのアジア市場分析
・ミドスタウリンの中南米市場分析
・ミドスタウリンの中東・アフリカ市場分析
・関連企業情報:Novartis
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Rydapt is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis.North America is the largest Sales place, with a Sales market share nearly 75.2% In 2018. Following North America, Europe is the second largest Sales place with the Sales market share of 24.8%. In USA, The National Cancer Institute estimates that In 2018 approximately 21,380 people will be diagnosed with AML and 10,590 may die of the disease. About one-third of these AML patients will have a FLT3 gene mutation.
In 2019, the global Rydapt market size was US$ 218 million and is forecast to US$ 859 million in 2026, growing at a CAGR of 21.4% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Rydapt.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Rydapt market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Rydapt market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Rydapt market. Readers of the report can become informed about current and future trends of the global Rydapt market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Rydapt markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Rydapt market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Rydapt market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Rydapt market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Rydapt market is segmented into
AML
ASM, SM-AHN, or MCL

Market Segment by Application, the Rydapt market is segmented into
Hospital
Pharmacy

This report includes the following manufacturers; we can also add the other companies as you want.
Novartis

The study objectives are:
To analyze and research the global Rydapt status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Rydapt manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Rydapt are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Rydapt Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Rydapt Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 AML
1.3.3 ASM, SM-AHN, or MCL
1.4 Market Segment by Application
1.4.1 Global Rydapt Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospital
1.4.3 Pharmacy
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Rydapt Revenue (2015-2026)
2.1.1 Global Rydapt Revenue (2015-2026)
2.1.2 Global Rydapt Sales (2015-2026)
2.2 Rydapt Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Rydapt Sales by Regions (2015-2020)
2.2.2 Global Rydapt Revenue by Regions (2015-2020)
2.3 Global Top Rydapt Regions (Countries) Ranking by Market Size
2.4 Rydapt Industry Trends
2.4.1 Rydapt Market Top Trends
2.4.2 Market Drivers
2.4.3 Rydapt Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Rydapt Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Rydapt Manufacturers by Sales (2015-2020)
3.1.1 Global Rydapt Sales by Manufacturers (2015-2020)
3.1.2 Global Rydapt Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Rydapt Sales in 2019
3.2 Global Top Manufacturers Rydapt by Revenue
3.2.1 Global Rydapt Revenue by Manufacturers (2015-2020)
3.2.2 Global Rydapt Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Rydapt Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rydapt as of 2019)
3.4 Global Rydapt Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Rydapt Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Rydapt Market
3.7 Key Manufacturers Rydapt Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Rydapt Historic Market Review by Type (2015-2020)
4.1.2 Global Rydapt Sales Market Share by Type (2015-2020)
4.1.3 Global Rydapt Revenue Market Share by Type (2015-2020)
4.1.4 Rydapt Price by Type (2015-2020)
4.1 Global Rydapt Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Rydapt Sales Forecast by Type (2021-2026)
4.2.3 Global Rydapt Revenue Forecast by Type (2021-2026)
4.2.4 Rydapt Price Forecast by Type (2021-2026)

5 Global Rydapt Market Size by Application
5.1 Global Rydapt Historic Market Review by Application (2015-2020)
5.1.2 Global Rydapt Sales Market Share by Application (2015-2020)
5.1.3 Global Rydapt Revenue Market Share by Application (2015-2020)
5.1.4 Rydapt Price by Application (2015-2020)
5.2 Global Rydapt Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Rydapt Sales Forecast by Application (2021-2026)
5.2.3 Global Rydapt Revenue Forecast by Application (2021-2026)
5.2.4 Rydapt Price Forecast by Application (2021-2026)

6 North America
6.1 North America Rydapt Breakdown Data by Company
6.2 North America Rydapt Breakdown Data by Type
6.3 North America Rydapt Breakdown Data by Application
6.4 North America Rydapt Breakdown Data by Countries
6.4.1 North America Rydapt Sales by Countries
6.4.2 North America Rydapt Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Rydapt Breakdown Data by Company
7.2 Europe Rydapt Breakdown Data by Type
7.3 Europe Rydapt Breakdown Data by Application
7.4 Europe Rydapt Breakdown Data by Countries
7.4.1 Europe Rydapt Sales by Countries
7.4.2 Europe Rydapt Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Rydapt Breakdown Data by Company
8.2 Asia Pacific Rydapt Breakdown Data by Type
8.3 Asia Pacific Rydapt Breakdown Data by Application
8.4 Asia Pacific Rydapt Breakdown Data by Regions
8.4.1 Asia Pacific Rydapt Sales by Regions
8.4.2 Asia Pacific Rydapt Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Rydapt Breakdown Data by Company
9.2 Latin America Rydapt Breakdown Data by Type
9.3 Latin America Rydapt Breakdown Data by Application
9.4 Latin America Rydapt Breakdown Data by Countries
9.4.1 Latin America Rydapt Sales by Countries
9.4.2 Latin America Rydapt Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Rydapt Breakdown Data by Type
10.2 Middle East and Africa Rydapt Breakdown Data by Application
10.3 Middle East and Africa Rydapt Breakdown Data by Countries
10.3.1 Middle East and Africa Rydapt Sales by Countries
10.3.2 Middle East and Africa Rydapt Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Novartis Rydapt Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Novartis Rydapt Products and Services
11.1.5 Novartis SWOT Analysis
11.1.6 Novartis Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Rydapt Sales Channels
12.2.2 Rydapt Distributors
12.3 Rydapt Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Rydapt Sales Forecast (2021-2026)
13.1.1 Global Rydapt Sales Forecast by Regions (2021-2026)
13.1.2 Global Rydapt Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Rydapt Sales Forecast (2021-2026)
13.2.2 North America Rydapt Revenue Forecast (2021-2026)
13.2.3 North America Rydapt Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Rydapt Sales Forecast (2021-2026)
13.3.2 Europe Rydapt Revenue Forecast (2021-2026)
13.3.3 Europe Rydapt Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Rydapt Sales Forecast (2021-2026)
13.4.2 Asia Pacific Rydapt Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Rydapt Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Rydapt Sales Forecast (2021-2026)
13.5.2 Latin America Rydapt Revenue Forecast (2021-2026)
13.5.3 Latin America Rydapt Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Rydapt Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Rydapt Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Rydapt Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Novartis

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ミドスタウリンの世界市場2020-2026:AML、ASM、SM-AHN又はMCL(Global Rydapt Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。